PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsChlorthalidone
Chlorthalidone
Chlorthalidone, Clorpres, Combipres, Demi-regroton, Edarbyclor, Kerledex, Lopressidone, Regroton, Tenoretic, Thalitone (chlorthalidone) is a small molecule pharmaceutical. Chlorthalidone was first approved as Hygroton on 1982-01-01. It is used to treat edema, glomerulonephritis, heart failure, hypertension, and liver cirrhosis amongst others in the USA. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 14, carbonic anhydrase 1, carbonic anhydrase 12, and carbonic anhydrase 4.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
digestive system diseasesD004066
urogenital diseasesD000091642
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Chlorthalidone, Thalitone (discontinued: Chlorthalidone, Hygroton, Thalitone)
Combinations
Atenolol chlorthalidone, Edarbyclor, Tenoretic (discontinued: Atenolol chlorthalidone, Clonidine chlorthalidone, Clorpres, Combipres, Demi-regroton, Kerledex, Lopressidone)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chlorthalidone
+
Clonidine hydrochloride
Tradename
Company
Number
Date
Products
COMBIPRESBoehringer IngelheimN-017503 DISCN1982-01-01
3 products, RLD
Hide discontinued
Chlorthalidone
+
Metoprolol tartrate
Tradename
Company
Number
Date
Products
LOPRESSIDONENovartisN-019451 DISCN1987-12-31
2 products
Hide discontinued
Chlorthalidone
+
Reserpine
Tradename
Company
Number
Date
Products
REGROTONSanofiN-015103 DISCN1982-01-01
1 products
DEMI-REGROTONSanofiN-015103 DISCN1982-01-01
1 products
Hide discontinued
Chlorthalidone
Tradename
Company
Number
Date
Products
THALITONECasper PharmaN-019574 RX1988-12-20
2 products, RLD
Show 1 discontinued
Betaxolol hydrochloride
+
Chlorthalidone
Tradename
Company
Number
Date
Products
KERLEDEXSanofiN-019807 DISCN1992-10-30
2 products
Hide discontinued
Atenolol
+
Chlorthalidone
Tradename
Company
Number
Date
Products
TENORETIC 100TWi PharmaceuticalsN-018760 RX1984-06-08
1 products, RLD, RS
TENORETIC 50TWi PharmaceuticalsN-018760 RX1984-06-08
1 products, RLD
Azilsartan kamedoxomil
+
Chlorthalidone
Tradename
Company
Number
Date
Products
EDARBYCLORAzurityN-202331 RX2011-12-20
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
atenolol and chlorthalidoneANDA2024-11-25
chlorthalidoneANDA2025-01-02
edarbyclorNew Drug Application2024-02-01
tenoreticNew Drug Application2024-01-31
thalitoneNew Drug Application2019-12-30
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
heart failureHP_0001635D006333I50
hypertensionEFO_0000537D006973I10
glomerulonephritisHP_0000099D005921N05
liver cirrhosisEFO_0001422D008103K74.0
nephrotic syndromeEFO_0004255D009404N04
edemaHP_0000969D004487R60.9
substance withdrawal syndromeEFO_0005800D013375—
diarrheaHP_0002014D003967R19.7
muscle spasticityHP_0001257D009128—
glaucomaEFO_0000516D005901H40
Show 17 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Azilsartan Kamedoxomil / Chlorthalidone, Edarbyclor, Azurity
93872492031-07-01U-3
91692382030-02-04DP
90669362028-03-26DP
71575842025-05-22DP
75729202025-01-07DPU-3
ATC Codes
C: Cardiovascular system drugs
— C03: Diuretics
— C03B: Low-ceiling diuretics, excl. thiazides
— C03BA: Sulfonamides, low-ceiling diuretics, plain
— C03BA04: Chlortalidone
— C03BB: Sulfonamides and potassium in combination, low-ceiling diruetics, excluding thiazides
— C03BB04: Chlortalidone and potassium
— C03E: Diuretics and potassium-sparing agents in combination
— C03EA: Low-ceiling diuretics and potassium-sparing agents
— C03EA06: Chlortalidone and potassium-sparing agents
HCPCS
No data
Clinical
Clinical Trials
104 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I10———1—1
Diabetes mellitusD003920HP_0000819E08-E13———1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameChlorthalidone
INNchlortalidone
Description
Chlorthalidone is a sulfonamide, a member of isoindoles and a member of monochlorobenzenes.
Classification
Small molecule
Drug classThiazide-like diuretic
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl
Identifiers
PDB—
CAS-ID77-36-1
RxCUI—
ChEMBL IDCHEMBL1055
ChEBI ID3654
PubChem CID2732
DrugBankDB00310
UNII IDQ0MQD1073Q (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
CA2
CA2
Organism
Homo sapiens
Gene name
CA2
Gene synonyms
NCBI Gene ID
760
Protein name
carbonic anhydrase 2
Protein synonyms
CA-II, CAC, Carbonate dehydratase II, carbonic anhydrase B, Carbonic anhydrase C, Carbonic anhydrase II, carbonic dehydratase, Cyanamide hydratase CA2, epididymis luminal protein 76, epididymis secretory protein Li 282
Uniprot ID
Q96ET9
Mouse ortholog
Car2 (12349)
carbonic anhydrase 2 (Q9DCY9)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Chlorthalidone
+
Atenolol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Chlorthalidone
+
Azilsartan
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Chlorthalidone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Chlorthalidone
+
Clonidine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 3,825 documents
View more details
Safety
Black-box Warning
Black-box warning for: Edarbyclor
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,576 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use